Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying Novocure Ltd (NVCR)

Page 1 of 2

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors’ money because they are without peer in the resources they use to identify the best investments for their chosen investment horizon. Moreover, they are more willing to invest a greater amount of their resources in small-cap stocks than big brokerage houses, and this is often where they generate their outperformance, which is why we pay particular attention to their best ideas in this space.

Novocure Ltd (NASDAQ:NVCR) investors should be aware of an increase in hedge fund sentiment lately. There were 6 hedge funds in our database with NVCR positions at the end of the previous quarter. At the end of this article we will also compare NVCR to other stocks including Kelly Services, Inc. (NASDAQ:KELYA), TerraForm Global Inc (NASDAQ:GLBL), and Sandy Spring Bancorp Inc. (NASDAQ:SASR) to get a better sense of its popularity.

Follow Novocure Ltd
Trade (NVCR) Now!

We follow over 700 hedge funds and other institutional investors and by analyzing their quarterly 13F filings, we identify stocks that they are collectively bullish on and develop investment strategies based on this data. One strategy that outperformed the market over the last year involves selecting the 100 best-performing funds and identifying the 30 mid-cap stocks that they are collectively most bullish on. Over the past year, this strategy generated returns of 18%, topping the 8% gain registered by S&P 500 ETFs. We launched this strategy 2.5 years ago and it returned more than 39% since then, vs. 22% gain registered by the S&P 500 ETFs.

Best Paying Medical Jobs with Least Education

With all of this in mind, we’re going to take a gander at the fresh action surrounding Novocure Ltd (NASDAQ:NVCR).

How have hedgies been trading Novocure Ltd (NASDAQ:NVCR)?

At the end of the third quarter, a total of 8 of the hedge funds tracked by Insider Monkey were long this stock, a jump of 33% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in NVCR over the last 5 quarters. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

NVCR Chart

Of the funds tracked by Insider Monkey, Highline Capital Management, led by Jacob Doft, holds the largest position in Novocure Ltd (NASDAQ:NVCR). According to regulatory filings, the fund has a $15.5 million position in the stock, comprising 0.5% of its 13F portfolio. The second most bullish fund manager is Stepstone Group, led by Jose Fernandez, which holds a $15.5 million position; 19.3% of its 13F portfolio is allocated to the stock. Some other peers that hold long positions encompass Justin John Ferayorni’s Tamarack Capital Management, Richard C. Patton’s Courage Capital and Kris Jenner, Gordon Bussard, Graham McPhail’s Rock Springs Capital Management. We should note that Courage Capital is among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2
Loading...